Tegan Texofab Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 04-07-2024
- Paid Up Capital ₹ 10.00 Cr
as on 04-07-2024
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 31.40 Cr
as on 04-07-2024
- Satisfied Charges ₹ 24.75 Cr
as on 04-07-2024
- Revenue 20.28%
(FY 2023)
- Profit -6.27%
(FY 2023)
- Ebitda -18.95%
(FY 2023)
- Net Worth -1.20%
(FY 2023)
- Total Assets 12.71%
(FY 2023)
About Tegan Texofab
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 10.00 Cr.
The company currently has active open charges totaling ₹31.40 Cr. The company has closed loans amounting to ₹24.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Tegan Texofab Private Limited India is Mrs Seth as COMPANY SECRETARY. Narendra Kothari, Rohit Seth, Sanjeev Mundhra, and One other member serve as directors at the Company.
- CIN/LLPIN
U17120DL2013PTC262515
- Company No.
262515
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Tegan Texofab Private Limited offer?
Tegan Texofab Private Limited offers a wide range of products and services, including Industrial Fabrics and Textiles, Coated Fabric.
Who are the key members and board of directors at Tegan Texofab?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mrs Seth  | Company Secretary | 01-Apr-2019 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Narendra Kothari | Director | 20-Dec-2013 | Current |
| Rohit Seth | Director | 23-Jun-2014 | Current |
| Sanjeev Mundhra | Director | 16-Jan-2014 | Current |
| Manishkumar Dudhani | Director | 24-Dec-2013 | Current |
Financial Performance of Tegan Texofab.
Tegan Texofab Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.28% increase. The company also saw a slight decrease in profitability, with a 6.27% decrease in profit. The company's net worth dipped by a decrease of 1.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tegan Texofab?
In 2023, Tegan Texofab had a promoter holding of 52.31% and a public holding of 47.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 26 Sep 2023 | ₹1.65 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 26 Oct 2020 | ₹15.00 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 26 Oct 2020 | ₹1.00 Cr | Open |
How Many Employees Work at Tegan Texofab?
Tegan Texofab has a workforce of 142 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tegan Texofab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tegan Texofab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
